The Latest
-
Milestone Pharmaceuticals Announces Regulatory Guidance and Updated Clinical Development Plan for Etripamil in PSVT
-
Dow to cut costs to blunt pandemic blow, signals choppy recovery
-
US House Passes Two Blockchain Amendments in Annual Defense Budget Bill
-
A Look At Immutep’s (ASX:IMM) Share Price Returns